Chemical formula: C₂₆H₂₄N₆O₂  Molecular mass: 452.196 g/mol  PubChem compound: 11950170

Therapeutic indications

Belumosudil is indicated for:

Chronic graft-versus-host disease

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Belumosudil is indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Belumosudil is contraindicated in the following cases:



Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.